Sandoz Asks Fed. Circ. To Wipe Out Allergan's $39M IP Award
By Andrew Karpan ( January 17, 2024, 5:30 PM EST) -- The Federal Circuit is being asked to weigh in on whether the company behind a popular eyebrow growth drug should have scored a $39 million verdict against Novartis' spun-off generic-drug making arm over a patent "related" to one thrown out by the same appeals court almost a decade ago....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.